BCL2L1 and B-cell non-Hodgkin lymphoma: Intriguingly, our Eμ‐MYC/Vav‐BCLX DT mice developed mainly IgM+ B cell lymphomas, like Eμ‐MYC mice lacking BIM 45 or BMF 46.